August 05.2020
AVATAMED Signed Contract with NanoFocusRay for overseas distribution of Mobile CT Phion 2.0

We are pleased to announce the signing of an overseas distributor contract for the the sales of NanoFocusRay Mobile CT Phion 2.0.

 

Please refer to press release:

http://www.newsa.co.kr/news/articleView.html?idxno=253132

http://www.hrdnews.org/news/articleView.html?idxno=4849

 

Phion 2.0 is a portable CT that can be installed and operated anywhere, providing for quick examinations in the field that can relieve patients' anxety. Radiation dosage is also one-fourth that of a normal CT, reducing the patient's radiation exposure burden.

 

Phion 2.0 was originally developed for musculoskeletal and spinal imaging, but due to the COVID-19 pandemic, it was also certified by the South Korean Ministry of Food and Drug Safety (MFDS) on 11 March 2020 for the diagnosis of COVID-19 patients.

 

Please visit www.avatahealthcare.com for more information.

 

NanoFocusRay Mobile CT Phion 2.0

August 05.2020
Prev
AVATAMED Partners CBmed in Europe on Precision Cancer Project
Next
AVATAMED Signed Distribution Agreement with BioTNS for the Sales of COVID-19 RT-PCR PNA Diagnostic Kits